Skip to content
10-Q

Quarterly Report

Biora Therapeutics, Inc.

0000950170-24-127060

← back to feed
Filed
Nov 14, 2024 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2024 · Nov 6, 2024 4.52M sh
Shares Diluted Q3 2024 · Sep 30, 2024 3.65M sh
Shares Diluted Q3 2024 · Sep 30, 2024 3.19M sh
Shares Diluted restated Q3 2024 · Sep 30, 2023 1.5M sh
Shares Diluted restated Q3 2024 · Sep 30, 2023 1.27M sh
Capex Q3 2024 · Sep 30, 2024 $214K
Capex Q3 2024 · Sep 30, 2023 $37K
Operating Cash Flow Q3 2024 · Sep 30, 2024 −$32.18M
Operating Cash Flow Q3 2024 · Sep 30, 2023 −$34.75M
Cash And Equivalents Q3 2024 · Sep 30, 2024 $3M
Stockholders Equity Q3 2024 · Sep 30, 2024 −$106.63M
Stockholders Equity Q3 2024 · Jun 30, 2024 −$89.32M
Stockholders Equity Q3 2024 · Mar 31, 2024 −$100.19M
Stockholders Equity Q3 2024 · Dec 31, 2023 −$101.42M
Stockholders Equity Q3 2024 · Sep 30, 2023 −$118.79M
Stockholders Equity Q3 2024 · Jun 30, 2023 −$120.88M
Stockholders Equity Q3 2024 · Mar 31, 2023 −$105M
Stockholders Equity Q3 2024 · Dec 31, 2022 −$102.29M
Current Liabilities Q3 2024 · Sep 30, 2024 $120.62M
Current Liabilities Q3 2024 · Dec 31, 2023 $62.97M
Total Liabilities Q3 2024 · Sep 30, 2024 $121.13M
Total Liabilities Q3 2024 · Dec 31, 2023 $132.64M
Current Assets Q3 2024 · Sep 30, 2024 $6.05M
Current Assets Q3 2024 · Dec 31, 2023 $19.07M
Total Assets Q3 2024 · Sep 30, 2024 $14.51M
Total Assets Q3 2024 · Dec 31, 2023 $31.22M
Eps Diluted Q3 2024 · Sep 30, 2024 −$5.04
Eps Diluted Q3 2024 · Sep 30, 2024 −$5.06
Eps Diluted restated Q3 2024 · Sep 30, 2023 −$48.89
Eps Diluted restated Q3 2024 · Sep 30, 2023 −$85.41
Eps Basic Q3 2024 · Sep 30, 2024 −$5.04
Eps Basic Q3 2024 · Sep 30, 2024 −$5.06
Eps Basic restated Q3 2024 · Sep 30, 2023 −$48.89
Eps Basic restated Q3 2024 · Sep 30, 2023 −$85.41
Sga Expense Q3 2024 · Sep 30, 2024 $10.65M
Sga Expense Q3 2024 · Sep 30, 2024 $28.1M
Sga Expense Q3 2024 · Sep 30, 2023 $12.77M
Sga Expense Q3 2024 · Sep 30, 2023 $30.08M
Rd Expense Q3 2024 · Sep 30, 2024 $5.61M
Rd Expense Q3 2024 · Sep 30, 2024 $20.32M
Rd Expense Q3 2024 · Sep 30, 2023 $10.55M
Rd Expense Q3 2024 · Sep 30, 2023 $23.72M
Net Income Q3 2024 · Sep 30, 2024 −$18.4M
Net Income Q3 2024 · Sep 30, 2024 −$16.13M
Net Income Q3 2024 · Jun 30, 2024 $6.47M
Net Income Q3 2024 · Mar 31, 2024 −$4.19M
Net Income Q3 2024 · Sep 30, 2023 −$73.45M
Net Income Q3 2024 · Sep 30, 2023 −$108.7M
Net Income Q3 2024 · Jun 30, 2023 −$17.81M
Net Income Q3 2024 · Mar 31, 2023 −$17.44M
Operating Income Q3 2024 · Sep 30, 2024 −$16.23M
Operating Income Q3 2024 · Sep 30, 2024 −$47.53M
Operating Income Q3 2024 · Sep 30, 2023 −$23.32M
Operating Income Q3 2024 · Sep 30, 2023 −$53.8M
Revenue Q3 2024 · Sep 30, 2024 $32K
Revenue Q3 2024 · Sep 30, 2024 $892K
Revenue Q3 2024 · Sep 30, 2023 $0
Revenue Q3 2024 · Sep 30, 2023 $4K